- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$1.14 BnMarket Estimate, 2026
$1.23 BnMarket Forecast, 2034
$2.25 BnCAGR, 2026–2034
7.83%Executive Summary: Middle East and Africa Nuclear Imaging Market
- Market Scope: Comprehensive Middle East and Africa nuclear imaging market analysis covering product types, clinical applications, end-user settings, country frameworks, and technological adoption drivers.
- Market Valuation: Valued at USD 1.14 billion (2025), estimated at USD 1.23 billion (2026), and projected to reach USD 2.25 billion by 2034, registering a robust CAGR of 7.83% (2026–2034).
- Primary Growth Drivers: Rising frequency of cancer and cardiac disorders, shift from standalone to hybrid modalities, advancements in radiotracers and data-integrated systems, and massive spending/investments in healthcare infrastructure via public-private partnerships. Key market constraints include high equipment costs, the short half-life of radiopharmaceuticals, supply instability (such as Tc-99m shortages), logistical challenges, and strict regulatory rules.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment (2025 Position) | Fastest-Growing Segment |
|---|---|---|
| By Product | Standalone SPECT and PET nuclear imaging systems (historical baseline market share) | Hybrid nuclear imaging systems (driven by multi-modality integration advantages) |
| By Application | Oncology (led clinical application workflows for tumor monitoring and cancer diagnostics) | Cardiology and advanced neurological disorder imaging applications |
| By End-User | Hospitals (represented the primary deployment setting for high-end nuclear equipment) | Specialized diagnostic centers and research facilities |
| By Country | South Africa and the UAE (accounted for leading regional market share backed by rising healthcare expenditure) | GCC countries and emerging MEA markets (projected to witness rapid expansion) |
Major Market Players & Market Structure
Market Structure: Growing regional technology landscape featuring major global medical equipment manufacturers and radiopharmaceutical developers expanding their footprint via healthcare investments and infrastructure modernization across MEA.
Key Companies: Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Company (Healthcare Division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging, Inc., Cardinal Health, Inc., and Bayer AG.
Middle East and Africa Nuclear Imaging Market Size
The Middle East and Africa nuclear imaging market size was valued at USD 1.14 billion in 2025 and is anticipated to reach USD 1.23 billion in 2026 from USD 2.25 billion by 2034, growing at a CAGR of 7.83% during the forecast period from 2026 to 2034
One of the key factors driving the market expansion is the rising frequency of cancer and heart disorders in the MEA region. Nuclear medicine holds a lot of promise in terms of cancer and heart disease treatment. The cancer burden is rising due to variables such as population aging, poor food, smoking, and physical inactivity. According to the World Health Organization, cancer incidence in the Middle East is rising, with many cases anticipated to quadruple by 2030. Minimally invasive procedures have aided the trend toward precise surgical treatment. Medical imaging-guided therapy is a new field that has applications in minimally invasive surgery, interventional radiology, and computer-aided visualization. The demand for imaging guidance has expanded due to these novel surgical procedures, as have the most advanced imaging methods. The shift from standalone to hybrid modalities, advances in radiotracers, the growing focus on personalized medicine, investments in diagnostic imaging centers through public-private partnerships, and the rising incidence and prevalence of cancer and cardiac ailments are all driving this market forward. The PET and SPECT market is being driven by rising knowledge of the benefits of nuclear imaging among physicians and clinical researchers and expanding application areas such as oncology and neurological diseases.
Nuclear medicine imaging is critical in diagnosing and managing patients with coronary artery disease (CAD), atherosclerosis, and other cardiovascular disorders in cardiology. Nuclear medicine is a key growth element for market analysis since it plays an important part in diagnosing and managing patients with various disorders. Image processing and reconstruction, computer-assisted medical condition recognition, 3D image production, and the employment of appropriate quality control systems are all possible with data integrated imaging systems. Physicians may compare scans with the use of data integration to monitor illness progression properly.
The primary restrictions for the MEA nuclear imaging market include rising research and development costs and highly advanced hybrid nuclear imaging equipment. Furthermore, the market's growth is further estimated to be hampered by the short half-life of radiopharmaceuticals, supply instability, logistical challenges, and rigorous regulatory rules, as well as competition from traditional alternative diagnostic techniques. In addition, increased costs of nuclear imaging equipment and a shortage of Tc-99m are among the primary reasons hindering market expansion and posing further challenges to the nuclear imaging devices market in the forecast period.
In terms of market share, South Africa leads the market in this region. Other significant markets in this region include UAE, Israel, and Nigeria. The massive rise in spending in the healthcare division in this region has increased Nuclear Imaging devices' demand, thereby providing lucrative growth prospects for the Nuclear Imaging device manufacturers. Due to technical improvements in the healthcare business and rising healthcare expenditure, the UAE dominates the Middle East and Africa market. The rapid rise in this region can be due to increasing chronic disease incidence, increased awareness of the benefits of early disease detection, and improved healthcare systems in the region. In the forecasted period, rising technical improvements, increased demand for qualified professionals, increased demand for data integrated imaging systems, and increased demand in the region will provide new opportunities for the nuclear imaging equipment market.
KEY MARKET PLAYERS
Companies playing a vital role in the Middle East & Africa Nuclear Imaging market include
- Mallinckrodt plc
- Siemens Medical Solutions
- Hitachi Medical Corporation
- Medtronic Inc.
- General Electric Company (Healthcare Division)
- IBA Group
- Positron Corporation
- Philips Medical Systems
- Naviscan
- Toshiba Medical Systems Corporation
- Carestream Health
- Lantheus Medical Imaging, Inc.
- Cardinal Health, Inc.
- Bayer AG
MARKET SEGMENTATION
This research report on the Middle East and Africa Nuclear Imaging Market has been segmented & sub-segmented into the following categories:
By Product
- Standalone PET Nuclear Imaging
- Standalone SPECT Nuclear Imaging
- Hybrid Nuclear Imaging
By Application
- Oncology
- Cardiology
- Neurology
- Others
By End-User
- Hospitals
- Diagnostic Centers
- Research Centers
By Country
- KSA
- UAE
- Israel
- rest of GCC countries
- South Africa
- Ethiopia
- Kenya
- Egypt
- Sudan
- rest of MEA